Expect a clash at today’s FDA peptide panel
The service members who refused the Covid vaccine, the fastest-growing Ebola outbreak in history, and other health news…
Read at source →Source
STAT News
Medicine, biotech, and health policy
Health · 283 articles · page 8 of 8 · fetched 14 minutes ago
STAT+: New data on Eli Lilly’s ‘triple-G’ drug leave open questions on heart benefit
On analyses that looked at major cardiovascular events, those taking retatrutide did not have a significant lower risk…
Read at source →
Filing of bipartisan Senate bill boosts momentum for office of men’s health
Mirroring the bipartisan bill introduced in the House, the measure would require a study from the GAO on the state of…
Read at source →
AdSponsoredSiguimi
Pure chronological social — no algorithm
See who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →STAT+: FDA staff and peptide enthusiasts set to clash at advisory panel
FDA advisers are set to consider whether allowing compounding pharmacies to offer largely unproven peptides is a safer…
Read at source →
Opinion: Good riddance to bundled ‘global’ maternal care billing
New maternal billing codes should create a transparent system where both patients and clinicians can thrive, ACOG…
Read at source →
Opinion: New billing codes likely to raise maternity care costs
“This change is likely to lead to only modest increases in total medical expenses. However, it coincides with many…
Read at source →
STAT+: Trump promised redemption for troops who refused Covid shots. A year later, many are still waiting
Veterans who want to rejoin the military are often bogged down in bureaucratic red tape.
Read at source →
STAT+: What is a ‘world model’? Nabla’s Alex LeBrun explains
In this edition of AI Prognosis, Brittany Trang talks to Alex LeBrun, AI scribe company Nabla's executive chairman,…
Read at source →
New study supports testing of Merck’s Ebola vaccine in DRC outbreak
New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses,…
Read at source →
Opinion: What Argentina’s World Cup loss should teach American hospitals
“Hospitals often make Argentina’s mistake: We confuse continuity with progress,” writes physician, hospital…
Read at source →
Congo’s Ebola outbreak has killed over 1,000 people
At least 999 people have died from the Ebola outbreak in Congo, a grim toll in what’s already been declared the fastest…
Read at source →Congo’s Ebola outbreak has killed nearly 1,000 people
At least 999 people have died from the Ebola outbreak in Congo, a grim toll in what’s already been declared the fastest…
Read at source →
STAT+: Pharma tries to tamp down broad China restrictions
AI-focused VC firm raises $800M, Merck's new cholesterol pill, and more biotech news from The Readout
Read at source →
STAT+: Pharmalittle: We’re reading about Trump’s plan for tariffs on generics, a Merck and Gilead HIV pill, and more
President Trump plans to impose tariffs on imported generic medicines, his latest threat aimed at bringing…
Read at source →
Job dissatisfaction and health care access uncertainty grows in the U.S., new study finds
What Hawaii's wildfires can teach the nation about health recovery, 4.5 million people disenrolled from SNAP, and more…
Read at source →
STAT+: ‘Cochlear implant for blindness’ debuts in Europe, could launch in U.S. in 2027
Science Corporation announced the European launch of its retinal implant for patients with age-related macular…
Read at source →
STAT+: Federal health quality research grants worth $109 million ended early
At least 78 AHRQ grants worth $200 million have been affected by "non-award" notices; it's estimated those grants had…
Read at source →
Opinion: STAT+: I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changer
“In truth, I don’t anticipate prescribing patterns changing immediately,” cardiologist Vishal Khetpal writes of the new…
Read at source →
Opinion: STAT+: Hospitals’ AI may be drifting. Who’s watching?
Senior leaders must treat AI governance as their own daily job, not something the technology committee handles…
Read at source →
As Maui recovers from devastating fires, a study offers vision for new rural health model
A study of the long-term health impact of the Lahaina wildfires is inspiring a new model for disaster recovery and…
Read at source →
STAT+: More workers hate their jobs, but keep them for the health insurance
A new survey reveals 24% of U.S. workers stay in unwanted jobs to keep health insurance. Experts call it 'job lock.'
Read at source →
Trump administration says it’s deferring $1B in Medicaid payments to California and Minnesota
The Trump administration said it was deferring more than $1 billion in Medicaid payments to Minnesota and California…
Read at source →
STAT+: Rare disease drugmakers try to avoid Trump price cuts
Plus, GOP voters want a crackdown on health care fraud, and how PBMs are skirting state laws.
Read at source →
Opinion: Pete Hegseth, ‘The Odyssey,’ and the testosterone myth
The poet didn’t say “sing to me, Muse, of a man with optimized endocrine panels," writes urologist Elizabeth Dray.
Read at source →
STAT+: Advocates say federal funding is being cut from groups fighting HIV
The administration is shifting some funding to states, but community groups are set to lose out.
Read at source →
Is there an exodus underway at Epic?
In this edition of STAT Health Tech: executive departures at Epic Systems, new CEO takes over at Nabla, and more health…
Read at source →
STAT+: Broad Institute, partners unveil new initiative to develop gene therapies for rare diseases
The Broad Institute, Boston Children’s Hospital, and Maine’s Jackson Laboratory announced a collaboration to develop…
Read at source →
STAT+: Anthropic deepens work with rare disease drugs
Novo Nordisk sues Eli Lilly over GLP-1s, Medicare pricing plans, and more biotech news from The Readout
Read at source →STAT+: Pharmalittle: We’re reading about Novo suing Lilly over ‘deceptive’ ads, a fugitive’s secret life in biotech, and more
Novo Nordisk sued Eli Lilly for allegedly running “deceptive” ads to make its obesity and diabetes drugs appear more…
Read at source →
STAT+: Nabla’s new CEO on plan to gain market share in a competitive AI scribe environment
Ambient scribe developer Nabla said Brian Manning will be the Paris-based company's new CEO as it looks to grow in a…
Read at source →
STAT+: Novo Nordisk sues Eli Lilly over GLP-1 drug ads it calls ‘deceptive’
Novo Nordisk sued Eli Lilly for allegedly running a “deceptive” ad campaign that uses “outdated clinical trials” to…
Read at source →